BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 30721098)

  • 1. Liver-specific knockdown of long-chain acyl-CoA synthetase 4 reveals its key role in VLDL-TG metabolism and phospholipid synthesis in mice fed a high-fat diet.
    Singh AB; Kan CFK; Kraemer FB; Sobel RA; Liu J
    Am J Physiol Endocrinol Metab; 2019 May; 316(5):E880-E894. PubMed ID: 30721098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A role for long-chain acyl-CoA synthetase-4 (ACSL4) in diet-induced phospholipid remodeling and obesity-associated adipocyte dysfunction.
    Killion EA; Reeves AR; El Azzouny MA; Yan QW; Surujon D; Griffin JD; Bowman TA; Wang C; Matthan NR; Klett EL; Kong D; Newman JW; Han X; Lee MJ; Coleman RA; Greenberg AS
    Mol Metab; 2018 Mar; 9():43-56. PubMed ID: 29398618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.
    Kan CF; Singh AB; Dong B; Shende VR; Liu J
    Biochim Biophys Acta; 2015 May; 1851(5):577-87. PubMed ID: 25645621
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methionine restriction prevents the progression of hepatic steatosis in leptin-deficient obese mice.
    Malloy VL; Perrone CE; Mattocks DA; Ables GP; Caliendo NS; Orentreich DS; Orentreich N
    Metabolism; 2013 Nov; 62(11):1651-61. PubMed ID: 23928105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of a novel function of hepatic long-chain acyl-CoA synthetase-1 (ACSL1) in bile acid synthesis and its regulation by bile acid-activated farnesoid X receptor.
    Singh AB; Dong B; Xu Y; Zhang Y; Liu J
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Mar; 1864(3):358-371. PubMed ID: 30580099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GLP-1 Elicits an Intrinsic Gut-Liver Metabolic Signal to Ameliorate Diet-Induced VLDL Overproduction and Insulin Resistance.
    Khound R; Taher J; Baker C; Adeli K; Su Q
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2252-2259. PubMed ID: 29074588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial deficiency of CTRP12 alters hepatic lipid metabolism.
    Tan SY; Little HC; Lei X; Li S; Rodriguez S; Wong GW
    Physiol Genomics; 2016 Dec; 48(12):936-949. PubMed ID: 27815536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Novel Function of Hepatic FOG2 in Insulin Sensitivity and Lipid Metabolism Through PPARα.
    Guo Y; Yu J; Deng J; Liu B; Xiao Y; Li K; Xiao F; Yuan F; Liu Y; Chen S; Guo F
    Diabetes; 2016 Aug; 65(8):2151-63. PubMed ID: 27207553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naringenin prevents dyslipidemia, apolipoprotein B overproduction, and hyperinsulinemia in LDL receptor-null mice with diet-induced insulin resistance.
    Mulvihill EE; Allister EM; Sutherland BG; Telford DE; Sawyez CG; Edwards JY; Markle JM; Hegele RA; Huff MW
    Diabetes; 2009 Oct; 58(10):2198-210. PubMed ID: 19592617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion.
    Klett EL; Chen S; Edin ML; Li LO; Ilkayeva O; Zeldin DC; Newgard CB; Coleman RA
    J Biol Chem; 2013 Jul; 288(30):21618-29. PubMed ID: 23766516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of Milk Fat Metabolism-Related Pathways of the Bovine Mammary Gland during Mid and Late Lactation and Functional Verification of the
    Fan Y; Han Z; Lu X; Zhang H; Arbab AAI; Loor JJ; Yang Y; Yang Z
    Genes (Basel); 2020 Nov; 11(11):. PubMed ID: 33207796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-chain acyl-CoA synthetase 4 participates in the formation of highly unsaturated fatty acid-containing phospholipids in murine macrophages.
    Kuwata H; Nakatani E; Shimbara-Matsubayashi S; Ishikawa F; Shibanuma M; Sasaki Y; Yoda E; Nakatani Y; Hara S
    Biochim Biophys Acta Mol Cell Biol Lipids; 2019 Nov; 1864(11):1606-1618. PubMed ID: 31376475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Liver-specific loss of long chain acyl-CoA synthetase-1 decreases triacylglycerol synthesis and beta-oxidation and alters phospholipid fatty acid composition.
    Li LO; Ellis JM; Paich HA; Wang S; Gong N; Altshuller G; Thresher RJ; Koves TR; Watkins SM; Muoio DM; Cline GW; Shulman GI; Coleman RA
    J Biol Chem; 2009 Oct; 284(41):27816-27826. PubMed ID: 19648649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Niacin increases diet-induced hepatic steatosis in B6129 mice.
    Fang H; Li Z; Graff EC; McCafferty KJ; Judd RL
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Sep; 1865(9):158731. PubMed ID: 32404278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic SH2B1 and SH2B2 regulate liver lipid metabolism and VLDL secretion in mice.
    Sheng L; Liu Y; Jiang L; Chen Z; Zhou Y; Cho KW; Rui L
    PLoS One; 2013; 8(12):e83269. PubMed ID: 24358267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysosomal acid lipase regulates VLDL synthesis and insulin sensitivity in mice.
    Radović B; Vujić N; Leopold C; Schlager S; Goeritzer M; Patankar JV; Korbelius M; Kolb D; Reindl J; Wegscheider M; Tomin T; Birner-Gruenberger R; Schittmayer M; Groschner L; Magnes C; Diwoky C; Frank S; Steyrer E; Du H; Graier WF; Madl T; Kratky D
    Diabetologia; 2016 Aug; 59(8):1743-52. PubMed ID: 27153842
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Myonectin deletion promotes adipose fat storage and reduces liver steatosis.
    Little HC; Rodriguez S; Lei X; Tan SY; Stewart AN; Sahagun A; Sarver DC; Wong GW
    FASEB J; 2019 Jul; 33(7):8666-8687. PubMed ID: 31002535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central Sfrp5 regulates hepatic glucose flux and VLDL-triglyceride secretion.
    Li Y; Tian M; Yang M; Yang G; Chen J; Wang H; Liu D; Wang H; Deng W; Zhu Z; Zheng H; Li L
    Metabolism; 2020 Feb; 103():154029. PubMed ID: 31770545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overproduction of altered VLDL in an insulin-resistance rat model: Influence of SREBP-1c and PPAR-α.
    Lucero D; Miksztowicz V; Macri V; López GH; Friedman S; Berg G; Zago V; Schreier L
    Clin Investig Arterioscler; 2015; 27(4):167-74. PubMed ID: 25796423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARα agonist WY-14,643 induces the PLA2/COX-2/ACOX1 pathway to enhance peroxisomal lipid metabolism and ameliorate alcoholic fatty liver in mice.
    Xu Y; Denning KL; Lu Y
    Biochem Biophys Res Commun; 2022 Jul; 613():47-52. PubMed ID: 35526488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.